Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness
Clinical trial NCT05903924 · COMPLETED
Trial details
- NCT number
- NCT05903924
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-09
- Primary completion
- 2024-04-06
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.